The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ELCC 2021 | Exciting updates in radiotherapy at ELCC 2021
Umberto Ricardi, MD, University of Turin, Turin, Italy, outlines the latest developments in radiotherapy for patients with lung cancer, highlighting the ability to improve treatment of brain metastases with radiosurgery, and novel hippocampal avoidance radiotherapy. Prof. Ricardi also discusses the potential role of proton therapy, hybrid machine learning, and immunotherapies. This video was recorded at the virtual European Lung Cancer Congress (ELCC) 2021.
